In addition, high expression of NLRP3 is associated with poor prognosis in BC patients [78], and lack of a functional inflammasome reduces natural killer (NK) cell recruitment and activation in the BC microenvironment [79]. This evidence concerns the gene NLRP3 and breast cancer.